Rafael Segarra

5PUBLICATIONS
8CO-AUTHORS
Toxicology (incl. clinical toxicology)Psychosocial aspects of childbirth and perinatal mental healthNeurology and neuromuscular diseasesPharmaceutical delivery technologiesHealth psychology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 04, 2024
Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis.

Giovanni Vita, Angelantonio Tavella, Giovanni Ostuzzi

|Feb 21, 2022
Long-acting injectable aripiprazole in pregnant women with schizophrenia: a case-series report.

Blanca Fernández-Abascal, Maria Recio-Barbero, Margarita Sáenz-Herrero

|Jul 01, 2021
Characterization of dopamine D2 receptor coupling to G proteins in postmortem brain of subjects with schizophrenia.

Iker Egusquiza, Eva Munarriz-Cuezva, Rafael Segarra

|May 19, 2021
Oral and Palmitate Paliperidone Long-Acting Injectable Formulations' Use in Schizophrenia Spectrum Disorders: A Retrospective Cohort Study from the First Episode Psychosis Intervention Program (CRUPEP).

R Segarra, M Recio-Barbero, M Sáenz-Herrero

|Jun 02, 2020
Deafness and mental health: Clinical challenges during the COVID-19 pandemic.

María Recio-Barbero, Margarita Sáenz-Herrero, Rafael Segarra

Pageof 1

Frequent Collaborators

2 joint publications

María Recio-Barbero

1 joint publications

Margarita Sáenz-Herrero

1 joint publications

Eva Munarriz-Cuezva

1 joint publications

Luis F Callado